My SciELO
Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Revista de la Sociedad Española del Dolor
Print version ISSN 1134-8046
Abstract
SANCHEZ-SALAZAR, CA; KRIKORIAN, A and ARIAS-BOTERO, JH. Impact on quality of life, depression and analgesic use, are associated with suffering in fibromyalgia patients. A cross-sectional study. Rev. Soc. Esp. Dolor [online]. 2023, vol.30, n.3, pp.159-167. Epub Mar 04, 2024. ISSN 1134-8046. https://dx.doi.org/10.20986/resed.2023.4061/2023.
Introduction:
Fibromyalgia (FM) is a complex disorder with significant impact on public health. Few studies have explored suffering in FM, since its approach focuses on pain management.
Objective:
To estimate the prevalence of suffering in patients with FM and its association with impact on quality of life, emotional distress, loneliness, vital stress and clinical and sociodemographic factors in a private healthcare institution in Medellín (Colombia).
Method:
A cross-sectional study was conducted in an institution specialized in chronic pain management. The degree of suffering (PRISM), level of pain (EVA), impact of FM (FIQR), loneliness (UCLA), anxiety and depression (HADS), stressful life events (CSV) and sociodemographic and clinical characteristics were evaluated. An explanatory model was proposed using logistic regression.
Results:
55.5 % IC95 (50,0-61,1) presented intense suffering. An explanatory model was obtained, where impact, depression and analgesic intake were the most relevant factors in intense suffering.
Discussion:
Patients with FM manifest an important suffering that should be attended by health personnel. Although pain is a relevant element, there are other factors to which attention should be paid, such as the impact of the disease on the person and the associated depression.
Keywords : Fibromyalgia; quality of life; psychological stress; pain; loneliness; anxiety.